IBD Industry Groups Bell Curve – Bullish Percent
The full post is available to view by members only. For immediate access:
Average Distribution: 51.28% (-1.66% 1wk)
- 58 Groups (29.15%) are in the Stage 4 zone (Weak)
- 72 Groups (36.18%) are in the Stage 1 or Stage 3 zone (Neutral)
- 69 Groups (34.67%) are in the Stage 2 zone (Strong)
The IBD Industry Groups Bell Curve decreased by -1.66% this week to finish at 51.28% overall.
The amount of groups in Stage 4 (Weak) increased by 3 (+1.5%), and the amount of groups in Stage 2 (Strong) decreased by 5 (-2.5%), while the amount groups in Stage 1 or Stage 3 (Neutral) increased by 2 (+1%).
The ratio of the amount of groups increasing in the Strong (Stage 2) zone versus decreasing in the Weak (Stage 4) zone decreased this week to 1.19, and so there are now 19% more groups in the Stage 2 zone as are in the Stage 4 zone.
However, it remains tilted slightly to the positive side of the scales, but the overall average distribution remains in a very neutral position. Hence, it continues to remains a selective stock pickers market.
New Feature: GICS Sub-industries Bell Curve
Members on the site now have access to the new GICS Sub-industries Bell Curve which is automatically updated daily and is interactive. So you can click into each Sub Industry page and see the individual stocks ordered by their Stage Analysis Technical Attributes (SATA) scores and Mansfield RS (Relative Strength) scores. The data only covers the S&P Composite 1500 currently, so there's a few groups with only a few stocks. But these will broaden out once the full US market data is added later this month.
Hence with this new data for the 163 Sub-industries update on the site daily, and more to be added with the same features for Sectors (11), Groups (25) and Industries (74) in the coming month. The IBD Industry Groups Bullish Percent post will be retired, and we will instead be using the GICS Bell Curves from the website.
Become a Stage Analysis Member:
To see more like this and other premium content, such as the regular US Stocks watchlist, detailed videos and intraday posts, become a Stage Analysis member.
Join Today
Disclaimer: For educational purpose only. Not investment advice. Seek professional advice from a financial advisor before making any investing decisions.